Basic Information
Carisma Therapeutics is a biotechnology company developing CAR macrophages, a disruptive immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cell therapy for the treatment of human diseases.
Carisma Therapeutics, Inc.
--
15~50 people
January 01, 2016
admin@carmatherapeutics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios